UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tralokinumab does not impact vaccine-induced immune responses: Results from a 30-week, randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitis

Journal of the American Academy of Dermatology, 2021-07, Vol.85 (1), p.71-78

2021

Volltextzugriff (PDF)

IL‐4 and IL‐13 both contribute to the homeostasis of human conjunctival goblet cells in vitro

Allergy (Copenhagen), 2022-08, Vol.77 (8), p.2555-2558

2022

Volltextzugriff (PDF)

Skin and systemic inflammation in adults with atopic dermatitis before and after whole-body topical betamethasone 17-valerate 0.1% or tacrolimus 0.1% treatment: A randomized controlled study

Journal of the European Academy of Dermatology and Venereology, 2024-07

2024

Volltextzugriff (PDF)

Corrigendum to “Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell-Th17 cell axis in psoriasis” [J. Dermatol. Sci. 81 (2016) 153–164]

Journal of dermatological science, 2017-02, Vol.85 (2), p.147-147

2017

Volltextzugriff (PDF)

Non‐invasive assessment of soluble skin surface biomarkers in atopic dermatitis patients—Effect of treatment

Skin research and technology, 2021-09, Vol.27 (5), p.715-722

2021

Volltextzugriff (PDF)

43946 Neutralization of IL-13 by tralokinumab improves atopic dermatitis endotypes characterized by S. aureus colonization

Journal of the American Academy of Dermatology, 2023-09, Vol.89 (3), p.AB198-AB198

2023

Volltextzugriff (PDF)

43966 Targeting interleukin-13 with tralokinumab reduces S. aureus abundance in adolescents with atopic dermatitis

Journal of the American Academy of Dermatology, 2023-09, Vol.89 (3), p.AB92-AB92

2023

Volltextzugriff (PDF)

40900 Tralokinumab modulates the transcriptomic profile of lesional and non-lesional skin in adolescents with moderate-to-severe atopic dermatitis assessed by tape-stripping

Journal of the American Academy of Dermatology, 2023-09, Vol.89 (3), p.AB241-AB241

2023

Volltextzugriff (PDF)

28170 Neutralizing interleukin-13 increases skin microbial diversity: Results from a phase 3, randomized, double-blind, placebo-controlled trial with tralokinumab in adult patients with atopic dermatitis

Journal of the American Academy of Dermatology, 2021-09, Vol.85 (3), p.AB177-AB177

2021

Volltextzugriff (PDF)

Targeting IL‐13 with tralokinumab normalizes type 2 inflammation in atopic dermatitis both early and at 2years

Allergy (Copenhagen), 2024-06, Vol.79 (6), p.1560-1572

2024

Volltextzugriff (PDF)

Key immune modulatory effects exerted by combination of calcipotriol and corticosteroid on psoriasis inflammation

Journal of dermatological science, 2016-10, Vol.84 (1), p.e102-e103

2016

Volltextzugriff (PDF)

Le tralokinumab module le profil transcriptomique de la peau (lésionnelle ou non) chez les adolescents atteints de dermatite atopique modérée à sévère

Annales de Dermatologie et de Vénéréologie - FMC, 2023-12, Vol.3 (8), p.A61

2023

Volltextzugriff (PDF)

Neutralizing Interleukin-13 with Tralokinumab Reduces Abundance of S. aureus in Adolescents with Atopic Dermatitis

Skin (Milwood, N.Y.), 2024-01, Vol.8 (1), p.s324

2024

Volltextzugriff (PDF)

Laser capture microdissection followed by next‐generation sequencing identifies disease‐related micro RNA s in psoriatic skin that reflect systemic micro RNA changes in psoriasis

Experimental dermatology, 2015-03, Vol.24 (3), p.187-193

2015

Volltextzugriff (PDF)

Neutralizing interleukin-13 increases skin microbial diversity: results from a Phase 3, randomized, double-blind, placebo-controlled trial of tralokinumab in adult patients with atopic dermatitis

Skin (Milwood, N.Y.), 2021-11, Vol.5 (6), p.s56

2021

Volltextzugriff (PDF)

Clinical Validation

Biomarker Validation, 2015, p.207-230

2015

Volltextzugriff (PDF)

Brodalumab, a Human Anti-Interleukin-17 Receptor A Monoclonal Antibody, Shows Low Immunogenicity in Patients with Moderate-to-Severe Psoriasis

Skin (Milwood, N.Y.), 2018-02, Vol.2, p.S1

2018

Volltextzugriff (PDF)

Ion transport mechanisms in native rabbit nasal airway epithelium

American journal of physiology. Lung cellular and molecular physiology, 1996-10, Vol.271 (4), p.637-L645

1996

Volltextzugriff (PDF)

Effects of a short-chain phospholipid on ion transport pathways in rabbit nasal airway epithelium

American journal of physiology. Lung cellular and molecular physiology, 1996-10, Vol.271 (4), p.646-L655

1996

Volltextzugriff (PDF)

Ion transport mechanisms in native rabbit nasal airway epithelium

American journal of physiology. Lung cellular and molecular physiology, 1996-10, Vol.15 (4), p.L637-L645

1996

Volltextzugriff (PDF)

Comparative Aspects of Actions of a Short-Chain Phospholipid on Epithelial Na + Channels and Tight Junction Conductance

Comparative biochemistry and physiology. A, Comparative physiology, 1997-10, Vol.118 (2), p.211-214

1997

Volltextzugriff (PDF)

Effects of a short-chain phospholipid on ion transport pathways in rabbit nasal airway epithelium

American journal of physiology. Lung cellular and molecular physiology, 1996-10, Vol.15 (4), p.L646-L655

1996

Volltextzugriff (PDF)

A Branch-and-Cut Algorithm for the Symmetric Two-Echelon Capacitated Vehicle Routing Problem

Transportation science, 2013-02, Vol.47 (1), p.23-37

2013

Volltextzugriff (PDF)

Multi-layer Access Control for SDN-Based Telco Clouds

Secure IT Systems, 2015, Vol.9417, p.197-204

2015

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(22)
Buchkapitel
(2)

Sprache

Englisch
(23)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(9)
Life Sciences & Biomedicine
(8)
Dermatology
(5)
Rabbits
(4)
Animals
(3)
Atopic Dermatitis
(3)
Biomarkers
(3)
Physiology
(3)
Respiratory System
(3)
Air Breathing
(2)
Biological And Medical Sciences
(2)
Cellular Biology
(2)
Dermatitis
(2)
Epithelium - Metabolism
(2)
Fundamental And Applied Biological Sciences. Psychology
(2)
Inflammation
(2)
Nasal Mucosa - Metabolism
(2)
Nose
(2)
Paracellular Pathway
(2)
Phosphatidylcholines - Pharmacology
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Tralokinumab does not impact vaccine-induced immune responses: Results from a 30-week, randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitis

IL‐4 and IL‐13 both contribute to the homeostasis of human conjunctival goblet cells in vitro

Skin and systemic inflammation in adults with atopic dermatitis before and after whole-body topical betamethasone 17-valerate 0.1% or tacrolimus 0.1% treatment: A randomized controlled study

Corrigendum to “Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell-Th17 cell axis in psoriasis” [J. Dermatol. Sci. 81 (2016) 153–164]

Non‐invasive assessment of soluble skin surface biomarkers in atopic dermatitis patients—Effect of treatment

43946 Neutralization of IL-13 by tralokinumab improves atopic dermatitis endotypes characterized by S. aureus colonization

43966 Targeting interleukin-13 with tralokinumab reduces S. aureus abundance in adolescents with atopic dermatitis

40900 Tralokinumab modulates the transcriptomic profile of lesional and non-lesional skin in adolescents with moderate-to-severe atopic dermatitis assessed by tape-stripping

28170 Neutralizing interleukin-13 increases skin microbial diversity: Results from a phase 3, randomized, double-blind, placebo-controlled trial with tralokinumab in adult patients with atopic dermatitis

Targeting IL‐13 with tralokinumab normalizes type 2 inflammation in atopic dermatitis both early and at 2years

Key immune modulatory effects exerted by combination of calcipotriol and corticosteroid on psoriasis inflammation

Le tralokinumab module le profil transcriptomique de la peau (lésionnelle ou non) chez les adolescents atteints de dermatite atopique modérée à sévère

Neutralizing Interleukin-13 with Tralokinumab Reduces Abundance of S. aureus in Adolescents with Atopic Dermatitis

Laser capture microdissection followed by next‐generation sequencing identifies disease‐related micro RNA s in psoriatic skin that reflect systemic micro RNA changes in psoriasis

Neutralizing interleukin-13 increases skin microbial diversity: results from a Phase 3, randomized, double-blind, placebo-controlled trial of tralokinumab in adult patients with atopic dermatitis

Clinical Validation

Brodalumab, a Human Anti-Interleukin-17 Receptor A Monoclonal Antibody, Shows Low Immunogenicity in Patients with Moderate-to-Severe Psoriasis

Ion transport mechanisms in native rabbit nasal airway epithelium

Effects of a short-chain phospholipid on ion transport pathways in rabbit nasal airway epithelium

Ion transport mechanisms in native rabbit nasal airway epithelium

Comparative Aspects of Actions of a Short-Chain Phospholipid on Epithelial Na + Channels and Tight Junction Conductance

Effects of a short-chain phospholipid on ion transport pathways in rabbit nasal airway epithelium

A Branch-and-Cut Algorithm for the Symmetric Two-Echelon Capacitated Vehicle Routing Problem

Multi-layer Access Control for SDN-Based Telco Clouds

Aktive Filter

Suchergebnisse filtern